Navidea Biopharmaceuticals Inc Asset Turnover Ratio (NAVB), as of third quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Navidea Biopharmaceuticals Inc   (NAVB)
 

Navidea Biopharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Sep 30 2023, Navidea Biopharmaceuticals Inc has not recorded any assets.
Visit Navidea Biopharmaceuticals Inc Balance sheet

Within sector Navidea Biopharmaceuticals Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Third Quarter 2023 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NAVB Asset Turnover Ratio (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Asset Change -8.94 % 228.3 % -34.27 % -34.21 % -30.15 %
Y / Y Revenue Change - - - -98.79 % -92.2 %
Asset Turnover Ratio (TTM) - - - 0.02 0.02
NAVB's Total Ranking # # # # #
Seq. Asset Change -30.67 % 247.18 % -45.84 % -30.15 % 149.96 %
Seq. Revenue Change - - - -91.88 % -86.93 %



Asset Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




NAVB Company Profile • Back to NAVB Efficiency Comparisons • Compare NAVB Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Assets at quarter ending Sep 30 2023
Allogene Therapeutics Inc 0.00 $ 0.186  Millions$ 762.937  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.